Publicaties van het Instituut voor Neuropathische Pijn

Hieronder vindt u een overzicht van de publicaties van Drs. D.J. Kopsky, arts.

Eenvoudig in het gebruik, geen bijwerkingen en vaak veel minder pijn! Dat is de conclusie na 15 jaar crème ontwikkeling (sinds 2010) en presentaties op internationale congressen en in medische tijdschriften.

Op het congres voor Europese pijnspecialisten in Florence, oktober 2013, werd zelfs een heel symposium gewijd aan het belang van pijnstilling via de huid En op het wereld congres voor pijn (IASP) in Boston (2018) gaven prof een didactische lezing voor een groot gehoor op uitnodiging van de IASP.

Ook op de 2018 zomer ‘pijnschool’ van de Europese en vereniging, de EFIC werd door hem een presentatie gegeven: ‘Topical innovation in the treatment of localized peripheral neuropathic pain: the case of phenytoin. The intimate relation between pathogenesis and mechanism of action’.

Aan deze internationale acties op verzoek van IASP en EFIC kan iedereen direct aflezen dat het werk wat we doen op mondiale schaal gewaardeerd wordt.

Pijn behandelen met pijnstillende crèmes

Het tijdschrift Pain Practice is een peer reviewed tijdschrift voor dokters die geïnteresseerd zijn in de behandeling van pijn. Daarin schreven we al veel eerder een eerste overzichtsartikel over dit onderwerp, de behandeling van chronische pijn met pijnstillende crèmes.[1]

Dit artikel kan ze helpen om de patiënt nog beter te behandelen, zeker wanneer de patiënt met pijn tegen bijwerkingen van de pillen oploopt. Dan kan gedacht worden aan onze pijnstillende crèmes, zonder bijwerkingen.

Samenwerking met academische en buitenlandse klinieken

We werken samen met collega’s uit diverse andere instituten en klinieken. Zo publiceerden we artikelen samen met een anesthesioloog uit Nijmegen en een neurochirurg uit Utrecht, en zijn een samenwerkingsverband aangegaan met de Ukrainse wetenschappelijke vereniging van pijnbestrijders.

Ook hebben we een wereldwijd netwerk van meer dan 1000 pijnspecialisten opgebouwd via linked-in. Dat alles om via uitwisseling van ideeën betere patiënten zorg te ontwikkelen. Wij worden regelmatig gevraagd op internationale congressen en bijscholingen.

Publicaties Drs. D.J. Kopsky – PubMed

(RSS Feed)

[wp_rss_retriever url=”https://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1bipEQobMwp2qZxS0clxyp9ejqGGMfRO6FGpT5F1c8qVThAkw_” items=”15″ excerpt=”0″ read_more=”true” credits=”false” new_window=”true” cache=”1 hour” thumbnail=”false” orderby=”date” date=”false” source=”false” dofollow=”true”]
Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome.
Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design.
Analgesic effects of topical ketamine.
Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%.
Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report.
Neuropathic pain as a result of acromegaly, treated with topical baclofen cream.
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.
Percutaneous nerve stimulation in chronic neuropathic pain patients due to spinal cord injury: a pilot study.
Central neuropathic pain in a patiënt with multiple sclerosis treated successfully with topical amitriptyline.
Intractable neuropathic pain in spinal intramedullary cavernoma treated successfully with a novel combination cream.
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patiënt with multiple sclerosis and central neuropathic pain.
Vulvodynia and proctodynia treated with topical baclofen 5 % and palmitoylethanolamide.
A novel spelling system for locked-in syndrome patients using only eye contact.
High doses of topical amitriptyline in neuropathic pain: two cases and literature review.
Topical amitriptyline in post-traumatic neuropathic pain.
Enhancing acupuncture by low dose naltrexone.
Nerve regeneration in neuropathic pain.
Letter to the editor.
A new combination cream for the treatment of severe neuropathic pain.
Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture.
Still no proof of the efficacy of acupuncture in the prevention of migraine.

– PubMed

(RSS Feed)

[wp_rss_retriever url=”https://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1R3QZIpFgeaVQItvWbt9P8OUMVxHdP3fPYRxjnFdC7rLu3Zczx” items=”15″ excerpt=”0″ read_more=”true” credits=”false” new_window=”true” cache=”1 hour” thumbnail=”false” orderby=”date” date=”false” source=”false” dofollow=”true”]
Effectiveness of the association micronized N-palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain.
Dermorphin: A Missed Palliative Care Opportunity for Intrathecal Therapy in Oncological Patients?
New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells.
The terms ‘autacoid’, ‘hormone’ and ‘chalone’ and how they have shifted with time.
Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome.
Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
Analgesic effects of topical ketamine.
Vulvodynia and proctodynia treated with topical baclofen 5 % and palmitoylethanolamide.
Neuropathic pain as a result of acromegaly, treated with topical baclofen cream.
Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold.
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.
Central neuropathic pain in a patiënt with multiple sclerosis treated successfully with topical amitriptyline.
Intractable neuropathic pain in spinal intramedullary cavernoma treated successfully with a novel combination cream.
Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report.
Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action.
Letter to the editor.
Spinal cord diseases: the concept ‘paraplegia’ in the interface of the 18th and 19th century.
Sertraline in the prevention of depression.
Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants.
Use and adverse reactions of local antibiotics and disinfectants on the skin.
Clinical and toxicological aspects of the use of ecstasy.
‘Smart drugs’ enticements on the Internet.
Prasterone (dihydroepiandrosterone): a modern source of eternal youth?
Evolution of concepts and definitions of Parkinson’s disease since 1817.
Romberg’s test; a century of discord over its implementation.
Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
Current developments in the field of multiple sclerosis.
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Hyperventilation-induced cerebral ischemia in panic disorder.
Serotonin, depression, and PDF.
Indications for lumbar puncture; shifts in diagnosis.
A new combination cream for the treatment of severe neuropathic pain.
Still no proof of the efficacy of acupuncture in the prevention of migraine.
A discussion from the previous century: multiple sclerosis or tabes dorsalis; or Friedreich’s disease?
Some historical aspects of Parkinson’s disease. The progression of insights in the period 1817-1868.

2019

  1. Kopsky DJ, Bhaskar AK, Zonneveldt HJ, JM, Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review. J. Pain Res. 2019; 12: 1189-1192. Link
  2. Russell AL, JM, Topical phenytoin in a case of severe fibromyalgia: ex juvantibus proof for fibromyalgia as a localized non-length dependent small fiber neuropathy. J Archives of Medical Case Reports and Case Study. 2019. Link

2018

  1. JM, A case of wasp-induced pain treated with topical phenytoin cream. J Clin Cases Rep 2018; 1(3): 106-108. PDF Academia
  2. JM, The quest for better analgesics for the treatment of peripheral neuropathic pain: navigating the sodium channels. Trends Gen Pract. 2018; 1(2): 2-3. Link
  3. JM, Notermans NC. Topical phenytoin formulations for pain in small fiber neuropathy, a pathogenetic approach. Gen Int Med Clin Innov. 2018; 3(1): 2-4. PDF
  4. JM, Topical NaV1.7 channel blocker failed in postherpetic Neuralgia (PHN): lessons to learn. Gen Med Open. 2018; 2(2): 1-2. Link
  5. JM, Mulder JK, Kopsky DJ, Rationale for the repositioning of phenytoin as a topical analgesic for peripheral neuropathic pain and a personalized and investigator-driven development plan. Ann Pharmacol Pharm. 2018; 3(2): 1144. Link
  6. JM, Topical phenytoin in painful diabetic neuropathy: rationale to select a non-selective sodium channel blocker. Clinical research in Neurology. 2018; 1(1): 1-5. Link
  7. JM, Phenytoin cream in painful diabetic neuropathy: support for development of new indications for generic drugs needed. Austin Neurology 2018; 3(1): 1011. PDF
  8. JM, Kopsky DJ, A single-blind n-of-1 study evaluating 4 different doses of phenytoin in a topical analgesic cream for the treatment of peripheral neuropathic pain. J Pain Manage Ther. 2018;2(1):17-20. Link
  9. JM, Kopsky DJ, The value of placebos to individualize pain therapy via a new single-blind test paradigm identifying responders on topical analgesic interventions. J Pain Relief 2018; 7: 313. PDF
  10. JM, Kopsky DJ, Small fiber burning pain in diabetic neuropathy in the elderly, treated with phenytoin cream. BAOJ Anesthesia 2018; 2(1): 003. PDF
  11. JM, Kopsky DJ, Neuropathic pain due to chronic idiopathic axonal neuropathy: fast pain reduction after topical phenytoin cream application. Open J Pain Med. 2018; 2(1): 007-008. PDF
  12. JM, Kopsky DJ, Opioid Receptors in the Skin. Austin J Anesthesia and Analgesia. 2018; 6(2): 1074. PDF
  13. JM, Kopsky DJ, Single-blind placebo-controlled response test with phenytoin 10% cream in neuropathic pain patients. Pharmaceuticals 2018; 11: 122. PDF
  14. JM, Kopsky DJ, On the importance of precision medicine for neuropathic pain. Pharm Pharmacol Int J. 2018;6(6):432-433. PDF
  15. JM, Kopsky DJ,Topical compounded analgesics for neuropathic pijn Topicale magistrale analgetica voor neuropathische pijn. Nederlandstalig Tijdschrift Pijnbestrijding. 2018; 37(73): 6-9. PDF
  16. JM, Kopsky DJ, Fast onset of relief after topical phenytoin in neuropathic pain after chemotherapy. Trends Cancer Res Chemother. 2018;1(1):1-3. PDF
  17. JM, Kopsky DJ, Small fiber burning pain in diabetic neuropathy in the elderly, treated with phenytoin cream. BAOJ Anesthesia 2018; 2(1): 003. Link
  18. JM, Kopsky DJ, Instituut voor Neuropathische Pijn, Repositioning problems of Clonidine as topical formulation in neuropathic pain. EC Pharmacology and Toxicology 2018; 6(8): 756-762. PDF
  19. JM, Kopsky DJ, Topical analgesics in localized neuropathic pain: transdermal delivery or intradermal? Anaesthesia, Critical Care and Pain Management. 2018; 1(2): 86-89. PDF
  20. JM, Kopsky DJ, A single-blind n-of-1 study evaluating 4 different doses of phenytoin in a topical analgesic cream for the treatment of peripheral neuropathic pain. J Pain Manage Ther. 2018;2(1):17-20. PDF
  21. JM, Pain in chemotherapy-induced peripheral neuropathy: NGF and the logic of topical phenytoin cream. J Case Rep Clin Images. 2018; 2: 1008. PDF
  22. JM, Chronobiology of neuropathic pain and the use of topical phenytoin in painful diabetic neuropathy. J Diabetol 2018; 2(2): 3-5. PDF
  23. JM, Phenytoin cream in painful diabetic neuropathy: an evolving chapter. J Diabetol 2018; 2(2): 6-8. PDF
  24. JM, A case of wasp-induced pain treated with topical phenytoin cream. J Clin Cases Rep 2018; 1(3): 106-108. Link
  25. JM, Posttranslational sodium ion channel modifications and the use of topical phenytoin in Painful Diabetic Neuropathy (PDN). Int J Diabetes Metab Disord 2018; 3(1)1-3. PDF
  26. JM, How to Define Neuroprotection: The Case of Phenytoin. Open Access J Neurol Neurosurg. 2018; 7(4): 555719. PDF
  27. JM, Kopsky DJ, The individualized N-of-1 trial: dose-response in a single-blind cross-over response test of phenytoin 10% and 30% cream in neuropathic pain. EC Anaesthesia 2018; 4(6):1-6. Link)
  28. JM, Single-blind placebo-controlled response on phenytoin 10% in painful diabetic neuropathy. Gen Med Open. 2018; 2(1): 2-3. Link
  29. JM, Phenytoin cream in painful diabetic neuropathy: support for development of new indications for generic drugs needed. Austin Neurology 2018; 3(1): 1011. PDF
  30. JM, Phenytoin: repurposing an old molecule and patent strategies for neuropathic pain. J Clin Trials Pat 2018;3(1): 3. PDF
  31. JM, A rationale for using gabapentinoids in topical analgesic formulations? Anaesthesia, Critical Care and Pain Management 2018; 1(3): 59-62. Link

2017

  1. JM, CR845 (Difelikefalin), A Kappa Receptors Agonist In Phase III By CARA Therapeutics: A Case Of ‘Spin’ In Scientic Writing?. J of Pharmacol & Clin Res. 2017; 2(3): 555588. DOI: 10.19080/JPCR.2017.02.555588 Link
  2. JM, Alan L Russell. The Role of Boron Salts in the Treatment of Symptoms in Osteoartrosis: Presentation of 2 Cases. JOJ Case Stud. 2017; 2(2) : 555582. Link
  3. JM, Idalopirdine (LY483518, SGS518, Lu AE 58054) in Alzheimer disease: never change a winning team and do not build exclusively on surrogates. Journal of pharmacology & clinical research (JPCR), 2017 Link
  4. JM, Moving targets in sodium channel blocker development: the case of raxatrigine: from a central NaV1.3 blocker via a peripheral NaV1.7 blocker to a less selective sodium channel blocker. J Med Therap, 2017,Volume 1(1): 1-3 doi: 10.15761/JMT.1000104 Link
  5. JM, Arguments to develop TRPV1 antagonist in neuropathic pain. Lessons for drug development. Clinical Research and Trials (CRT) 2017, DOI: 10.15761/CRT.1000165 Link
  6. JM, Primum non Nocere: Supplements As Analgesics, A Neglected Area. Editorial. J Pain Relief 2:e116. doi: 10.4172/2167-0846.1000e116 Link
  7. JM, Kopsky DJ, The use of topical compounded analgesic creams in neuropathic pain by the primary care physician. J Gen Pract (Los Angel) 2017; 5:345. Link
  8. JM, Topical Amitriptyline: can it reduce localized neuropathic pain? J Clin Trials Regul Aff. 2017; 1(1): 1-4. Link
  9. JM, Kopsky DJ, Instituut voor Neuropathische Pijn, Topical compounded analgesic treatment in neuropathic pain: 8 years of experience. J Pain Manage Med. 2017;3(2): 128. Link
  10. JM, Rethinking peripheral sensitization, peripheral neuropathic pain and the putative value of topical analgesics. J of Pharmacol & Clin Res. 2017; 4(2): 555631. Link
  11. JM, Repurposing phenytoin as an anti-aggression drug: clinical evidence. Neurol Disord Therap 2017; 1(4)1-5. Link
  12. JM, Kopsky DJ, Topical phenytoin cream in small fiber neuropathic pain: fast onset of perceptible pain relief. Int J Pain Relief. 2017;1(1): 015-019. PDF
  13. JM, Kopsky DJ, Phenytoin cream reduces pain and improves sleep in patients suffering from neuropathic pain. Austin J Anesthesia and Analgesia. 2017; 5(2): 1061. PDF
  14. JM, Kopsky DJ, Pain in chemotherapy induced peripheral neuropathy treated with topical phenytoin cream. CP Cancer Sci. 2017 1(2): 008. Link
  15. JM, Chiosi F, Rinaldi M, Di Staso S, Bartollino S, Costagliola C. Phenytoin: its potential as neuroprotective and retinoprotective drug. Br J Clin Pharmacol. 2017 Oct 12. PubMed
  16. JM, Kopsky DJ, Topical phenytoin cream reduces burning pain due to small fiber neuropathy in sarcoidosis. J Anesth Pain Med. 2017; 2(1): 1-3. Link
  17. JM, Amantadine and phenytoin: patent protected cases of drug repositioning Clin Invest. 2017; 7(1):11-16. Link
  18. JM, Kopsky DJ, Burning pain in small fibre neuropathy treated with topical phenytoin: rationale and case presentations. J Clin Anesth Pain Med. 2017; 1(1): 6. PDF Link
  19. JM, Kopsky DJ, Topical phenytoin in neuralgic pain, peripheral modulation of central sensitization: two case reports. J Pain Relief 2017; 6(2): 284. Link
  20. JM, Thinking out of the pillbox: the relevance to topiceuticals in the treatment of neuropathic pain. J Pain Relief 2016; 6(5): Link
  21. JM, Kopsky DJ, Instituut voor Neuropathische Pijn, Topical analgesic creams and nociception in diabetic neuropathy: towards a rationale fundament. Clin Case Rep Rev. 2016; 2(7): 500-502. Link
  22. JM, Topical analgesics: critical issues related to formulation and concentration. J Pain Relief 2016; 5(6):245. Link
  23. Kopsky DJ, Topical analgesia is a viable option. J Pain Relief 2016; 5(3):245. Link
  24. Kopsky DJ, Extending the therapeutic scope for the treatment of neuropathic pain with topical analgesics. J Pain Relief. 2016; 5(3): 251-252. Link

Publicaties van het INP 2016

  1. JM, A Novel α2δ1 Agonist for Neuropathic Pain: NVA1309 of Novassay. J of Pharmacol & Clin Res. 2016; 1(5): 555575. DOI: 10.19080/JPCR.2016.01.555575  PDF
  2. JM, Chiosi F, Costagliola C. Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold? Drug Des Devel Ther. 2016 Sep 27;10:3133-3141. Link
  3. JM, Autacoids: A New Fundament for Pain Medicine of the 21th Century. Anaesthesia, Critical Care and Pain Management 2016; 1: 3-6 Link

2014

  1. JM, Pain management. In: Syringomyelia, A Disorder of CSF Circulation. By Graham Flint, Clare Rusbridge (Edited by). Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 2014: 237-260 Link

2013

  1. JM, Palmitoylethanolamide: A Useful Adjunct in Chemotherapy Providing Analgesia and Neuroprotection. Chemotherapy: Open Access; 2013, 2:3 Link
  2. JM, Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator Palmitoylethanolamide: a case collection. Int Med Case Rep J. 2013 Sep 13;6:49-53. doi: 10.2147/IMCRJ.S51572 Link
  3. JM, Tineke de Boer, and Renger F. Witkamp, “Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold,” International Journal of Inflammation, vol. 2013, Article ID 151028, 8 pages, 2013. doi:10.1155/2013/151028 Link
  4. JM, Clinical neuro-restaurative effects of Palmitoylethanolamide due to Inhibition of inhibition of NF-kappaB?. Journal of Neuroinflammation 2013, 10:92 doi:10.1186/1742-2094-10-92  Link
  5. JM, Anti-inflammatory compounds, such as Ketamine and Palmitoylethanolamide as anti-depressants. Journal of Neuroinflammation 2013, 10:43 doi:10.1186/1742-2094-10-43 Link
  6. JM, Evolution in pharmacologic thinking around the natural analgesic Palmitoylethanolamide: agonist and effective nutraceutical PEA and the sociology of science . J Pain Res August 2013 Volume 2013:6 Pages 625b – 634 DOI: https://dx.doi.org/ Link
  7. JM, Professor Rita Levi-Montalcini on Nerve Growth Factor, Mast Cells and Palmitoylethanolamide (PEA), an Endogenous Anti-Inflammatory and Analgesic Compound. J Pain Relief 2013, 2:1 Link
  8. JM, Kopsky DJ, Witkamp RF. Palmitoylethanolamide (PEA)-‘promiscuous’ anti-inflammatory and analgesic molecule at the interface between nutrition and pharma, Pharma Nutrition (2013), j.phanu. 2013.11.127 Link

2012

  1. JM, Hekker TA, Therapeutic utility of Palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series, Journal of Pain Research, Volume 2012:5 Pages 437 – 442 Link
  2. JM, New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoylethanolamide. Open Pain Journal 2012, 5: 12-23 Link
  3. JM, Tabernanthe iboga. Folia Pharmaceutica; 100;2:18-19 Link
  4. JM, Kopsky, DJ, Instituut voor Neuropathische Pijn, Neuropathische pijn. In NTvA 2012; 35:17-19

2011

  1. JM, Kopsky DJ, An integrative approach for the treatment of neuropathic pain. EU J Int Med 2010; 2 (4): 190. Link
  2. JM, Kopsky DJ, A quality indicator for CAM interventions: The IOCOB traffic light grading system . EU J Int Med 2010; 2 (4): 242. Link
  3. JM, Kopsky DJ, Nerve Regeneration in Neuropathic Pain Pain Med 2010 Okt, 11(10):1576.r=21199307 Link
  4. JM, Kopsky DJ, A new combination cream for the treatment of severe neuropathic pain. J Pain Symptom Manage. 2010 Feb;39(2):e9-e10.r=20152584 Link
  5. JM, (2011) Glia as a new target for neuropathic pain, clinical proof of concept for Palmitoylethanolamide (PEA), a glia-modulator.AnaesthesiaPain & Intensive Care. Link

Publicaties van het INP 2010

  1. Kopsky DJ, Yoga voor borstkankerpatiënten tijdens radiotherapie. Supplement 2010; 11(10):38.
  2. Kopsky DJ, Complementaire therapieën met een positief effect op de bijwerkingen van radiotherapie bij kanker. Supplement 2010; 11(9):38-39.
  3. Kopsky DJ, Acupunctuur bij kinderen (Onder de loep). Supplement 2010; 11(8):16-19.
  4. Kopsky DJ, Communicatie tussen kankerpatiënt en oncoloog. Supplement 2010; 11(8):38.
  5. Kopsky DJ, TENS bij xerostomie onderzocht. Supplement 2010; 11(8):48.
  6. Kopsky DJ, Advies over fyto-oestrogenen aan borstkankerpatienten. Supplement 2010; 11(7):38.
  7. Kopsky DJ, Honing (Onder de loep). Supplement 2010; 11(7):58-61.
  8. Kopsky DJ, National Health Statistic Reports. Kosten van CAM-therapieen in de USA. Supplement 2010; 11(6):27.
  9. Kopsky DJ, Naar binnen kijken zorgt voor inzicht (Onder de loep) Supplement 2009; 10(8):18-19.
  10. Kopsky DJ, Hypnose bij overgewicht, een veilige interventie (Onder de loep). Supplement 2010; 11(1):22-23.
  11. Kopsky DJ, Acupuncture for cancer-Related fatigue. Supplement 2010; 11(1):43.
  12. Kopsky DJ, Trametes Versicolor. Supplement 2010; 11(1):51.
  13. Kopsky DJ, PM Nagel. Mind-Body therapieen, Oude technieken in een nieuw jasje. Supplement 2010; 11(1):70-71.
  14. Kopsky DJ, Oogbewegingstechniek bij posttraumatische stressstoornis. Supplement 2010; 11(3):28-31.
  15. Kopsky DJ, Integrative oncology deel I Supplement 2010; 11(3):42.
  16. Kopsky DJ, Integrative oncology deel II Supplement 2010; 11(4):38-39.
  17. Kopsky DJ, Interview met professor Lorenzo Cohen Supplement 2010; 11(5):10-13.
  18. Kopsky DJ, Maitake Supplement 2010; 11(5):42. Feb;39(2):e9-e10.

2009

  1. Kopsky DJ, Kruiden als medicijn?! De arts dient van het gebruik op de hoogte te zijn. Supplement 2009; 10(6):22-24.
  2. Kopsky DJ, JM, Beta-glucanen verlagen het cholesterol (Onder de loep) Supplement 2009; 10(1):14-17.
  3. Kopsky DJ, Naalden voor het hoofd, Acupunctuur bij migraine. Supplement 2009; 10(11):46-47.
  4. Kopsky DJ, JM, Mucuna Pruriens, Veelbelovend voor de behandeling van de ziekte van Parkinson Supplement 2009; 10(2):39-41.
  5. Kopsky DJ, Inleiding Laser bij wondgenezing. Supplement 2009; 10(12):31.
  6. Kopsky DJ, Vink C. Interview met Edzard Ernst, hoogleraar complementaire geneeskunde. Supplement 2009; 10(12):8-11.

2008

  1. Kopsky DJ, Boswellia: veelbelovend bij reuma, colitis en oedemen (Onder de loep). Supplement 2008; 9(8):32-35.
  2. JM, Kopsky DJ, boek: Met het oog op de naald. De fundamenten van de geneeskunde, Ankh Hermes, 2008.
  3. JM, Kopsky DJ, Collectieve plicht. Medisch Contact 2008;63(19):830-831. Link
  4. JM, Kopsky DJ, Salvia, van Alzheimer tot sjamaan (Onder de loep) Supplement 2008; 9(5):28-31.
  5. JM, Kopsky DJ, Bewijs voor complementaire behandelwijzen groeit (Onder de loep) Supplement 2008; 9(12):44-45.
  6. JM, Kopsky DJ, Onder de loep: P6, specifiek acupunctuurpunt bij postoperatieve misselijkheid en braken (Onder de loep). Supplement 2008; 9(2):34-35.
  7. JM, Kopsky DJ, Onder de loep: melisse. (Onder de loep). Supplement 2008; 9(3):40-41.
  8. JM, Kopsky DJ, Ginkgo Biloba, de levende dinosaurier (Onder de loep). Supplement 2008; 9(4):30-33.
  9. JM, Kopsky DJ, Boswellia: veelbelovend bij reuma, colitis en oedemen Supplement 2008; 9(10):51.

2007

  1. Kopsky DJ, JM, Verlichte mandarijnen (2) Medisch Contact 2007;62(41): 1694. Link
  2. Kopsky DJ, JM, Fusion in 2007: Acupunctuur en Hypnose Ned. Tijdschr. Acup. 2007;30(2):6-10.
  3. Kopsky DJ, JM, Yamamoto Schedelacupunctuur: interessante nieuwe feiten. Ned. Tijdschr. Acup. 2007;30(1):33-34.
  4. JM, Hypnotherapie, wetenschap en klinische toepasbaarheid. TETH 2007;juni: 18-21

2006 – Publicaties van het INP

  1. Kopsky DJ, JM, ZonMw wint kwakzalverijprijs. Medisch Contact 2006;61(49):1992. Link
  2. Kopsky DJ, JM, Methodologische problemen rond het meten van puntspecificiteit van acupunctuurpunten. Ned. Tijdschr. Acup. 2006;29(4):5-10.
  3. Kopsky DJ, JM, Communicatie, wetenschap en acupunctuur: een discussie over de waarde van acupunctuur in de media. Ned. Tijdschr. Acup. 2006;29(1):37-39.
  4. Kopsky DJ, JM, Onder de loep: behandeling van rugklachten. Veel mogelijkheden in therapieland (Onder de loep). Supplement 2006; 7(5):4-7.
  5. Kopsky DJ, JM, Chronische pijn: behandeling met segmentale, elektro- en TCM acupunctuur, een stappenplan. Ned. Tijdschr. Acup. 2006;29(2):11-13.

2005

  1. Kopsky DJ, JM, Nep-acupunctuur voorkomt spanningshoofdpijn (2) Medisch Contact 2005;60(38):1524. Link
  2. Kopsky DJ, JM, Acupunctuur en Fibromyalgie. Medisch Contact 2005;60(35):1405. Link
  3. Kopsky DJ, JM, YNSA: Yamamoto New Scalp Acupuncture. Ned. Tijdschr. Acup. 2005;28(1):26-28.
  4. Kopsky DJ, JM, Onderwijs Innovatie project Acupunctuur Ned. Tijdschr. Acup. 2005;28(4):32-34.
  5. Kopsky DJ, JM, Neuropathy. In: G. Albrecht et al. (eds.) Encyclopedia of Disability. Sage (2005).
  6. Kopsky DJ, JM, Acupuncture for bladder dysfunctions in Multiple Sclerose. J. Medical Acupuncture 2005;17(1)1-2.
  7. Kopsky DJ, JM, De Taoistische bron van het leven: de Tao Te King Ned. Tijdschr. Acup. 2005;28(3):11-15.
  8. Kopsky DJ, JM, Acupuncture in headache better than sham acupuncture? Results from a dose-finding trial! BMJ rapid response Link
  9. Kopsky DJ, Inventarisatie acupunctuur in Oostenrijk Ned. Tijdschr. Acup. 2005;28(1):29-30.
  10. JM, What Shall We Conclude From This Randomized Clinical Trial Of Acupuncture? Electronic letter Journal Internal medicine 2005

2004

  1. Kopsky DJ, JM, Compelementaire Behandelwijzen (3) Medisch Contact 2004; 37:1424. Link, (7) Medisch Contact 2004; 52:2068-2069. Link
  2. Kopsky DJ, JM, Visual Analogue Scale (VAS): een simpele methode om de effecten van acupunctuur vast te leggen. Ned. Tijdschr. Acup. 2004;27(2):20-21.
  3. Kopsky DJ, JM, Deurbeleid KNMG ter discussie (2) Medisch Contact 2004; 39:1506. Link
  4. Kopsky DJ, JM, Alternatieve hulp (2). Medisch Contact 2004;18:708-709. Link
  5. Kopsky DJ, JM, Complementaire geneeskunde. Medisch Contact 2004;36:1384-1385. Link, (3) Medisch Contact 2004; 37:1424. Link
  6. Kopsky DJ, JM, Visual Analogue Scale (VAS): een simpele methode om de effecten van acupunctuur vast te leggen. Ned. Tijdschr. Acup. 2004;27(2):20-21.
  7. Kopsky DJ, JM, Neuroacupunctuur, deel 1. Ned. Tijdschr. Acup. 2004;27(1):5-11.
  8. Kopsky DJ, JM, Tenniselleboog met acupunctuur behandelen. Ned. Tijdschr. Acup. 2004;27(4):5-7.
  9. Kopsky DJ, JM, Behandeling van angst met acupunctuur. Ned. Tijdschr. Acup. 2004;27(4):30-32.
  10. Kopsky DJ, JM, Acupunctuur en migraine. Ned. Tijdschr. Acup. 2004;27(2):29-31.
  11. Kopsky DJ, JM, Onderzoek en onderwijs van complementaire behandelwijzen en een opzet voor een inventarisatieonderzoek acupunctuurindicaties. Ned. Tijdschr. Acup. 2004;27(3):30-34.
  12. Kopsky DJ, JM, Complementaire geneeskunde. Medisch Contact 2004;59:1384-1385. Link
  13. Kopsky DJ, JM, Is een complementaire of experimentele therapie betrouwbaar? MenSen 2004; september 14-16.
  14. Kopsky DJ, JM, Alternatieve hulp. Medisch Contact 2004;59:708-709 Link
  15. Kopsky DJ, JM, Visual Analogue Scale (VAS): een simpele methode om de effecten van acupunctuur vast te leggen. Ned Tijdschr Acup. 2004;27(2):20-21.
  16. Kopsky DJ, JM, De droommeester methode. Wat te doen tegen nachtmerries. Bres 2004;228:okt-nov:54-61

2003

  1. Kopsky DJ, JM, Meditatieve Transpersoonlijke acupunctuur. Huang Ti 2003;25:24-27
  2. Kopsky DJ, JM, Kiezen voor alternatieve behandeling: een handleiding voor de patient. Contact, Vereniging voor Spierziekten, Oktober 2003,20-23 Link
  3. Kopsky DJ, JM, Het behandelen van Multiple sclerose met Neuroacupunctuur. MenSen 2003;11:14-16
  4. Kopsky DJ, JM, MS behandelen met neuroacupunctuur MSinfo 2003; 2(6)14-15.

Referentielijst

[1] Kopsky DJ, Keppel Hesselink JM. | High Doses of Topical Amitriptyline in Neuropathic Pain: Two Cases and Literature Review. | Pain Pract. | 2011 Jun 16. doi: 10.1111/j.1533-2500.2011.00477.x. [Epub ahead of print]